Adam Bonislawski (left) is a science writer with more than 10 years of experience covering genomic and proteomic research and diagnostics development with a focus on cancer and early detection. His writing ranges widely over academic research, companies and technologies. The publications he writes for, GenomeWeb and 360Dx, are read by thousands of cancer researchers and doctors as well as a wide range of healthcare entrepreneurs and investors, and he has scientific and media contacts at many of the major cancer and academic research centers in the United States and Europe. In addition to his work as a science writer, Adam writes about business and real estate for the Wall Street Journal, New York Post, and Commercial Observer.

EARLY DETECTION Catching Cancer When It’s Curable Bruce Ratner and Adam Bonislawski Ratner In an accessible yet fastidiously researched intervention Early Detection sets out the urgent necessity of fundamentally re-directing the US’s approach to cancer treatment if President Biden’s recently announced prioritization of the issue is to be successful. More